Senate Passes Fourth COVID-19 Spending Package, Includes $25Bn For Additional Testing, Contact Tracing

A Paycheck Protection Program and Health Care Enhancement Act bill that would dole out $25bn for additional testing by federal agencies and $75bn to Medicare suppliers providing testing equipment passed the US Senate on 21 April and is headed to the House for a vote.

collage with US capitol Building and American dollars on blurred background

The US Senate on 21 April approved a $484bn spending package providing tens of billions of dollars to compensate Medicare suppliers that have already supplied diagnoses, testing supplies and personal protection equipment (PPE) to detect the coronavirus, and $25bn more to expand COVID-19 testing.

House members, almost all of whom are self-quarantining or working in their home districts since the end of March, have been summoned back to Washington, DC, by House Speaker Nancy...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.